Akbar Indo Makmur Stimec Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Akbar Indo Makmur Stimec Tbk trades at Rp386 (market cap 84.48B, 88.3K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp306 (market cap 821.5B, 12.63M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 9.7× Akbar Indo Makmur Stimec Tbk's market cap, and Charlie Hospital Semarang Tbk. is more actively traded (12.63M versus 88.3K). Which is the better fit depends on your goals.
| AIMS | RSCH | |
|---|---|---|
Market Cap | 84.48B | 821.5B |
Volume | 88.3K | 12.63M |
Lot | 883 | 126.34K |
Turnover | 34.62M | 3.91B |
Average Price | 392.1 | 309.24 |
Value | 34.62M | 3.91B |
Indicative Equilibrium Price | 384 | 312 |
Indicative Equilibrium Volume | 200 | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.
Read more on AIMS →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →